biote Corp. Form 8-K Summary
Reporting date: January 17, 2024. The filing reports preliminary financial results for the three months and year ended December 31, 2023, and announces an agreement to acquire F.H. Investments, Inc., doing business as Asteria Health.
Business Context and Period
biote Corp. is a Delaware corporation whose Class A common stock trades on Nasdaq under the symbol BTMD. The filing was furnished under Items 2.02 and 7.01 and includes two press releases as Exhibits 99.1 and 99.2.
Financial Results and Metrics
The filing states that preliminary results for the quarter and full year ended December 31, 2023 were released. The provided filing text does not include the associated revenue, profit, cash flow, margin, debt, liquidity, or other financial figures.
Material Changes and Strategic Developments
- The company announced an agreement to acquire F.H. Investments, Inc., d/b/a Asteria Health.
- The provided text does not disclose the transaction price, consideration structure, expected closing date, financing terms, projected financial contribution, or other material transaction terms.
- Because the results are preliminary, they may differ from subsequently reported audited or finalized results.
Guidance, Outlook, Risks, and Unusual Items
The filing text provided does not include management guidance, an outlook, risk discussion, contingencies, or commentary regarding the acquisition or preliminary results. The press release contents are referenced but not reproduced.
Key Facts to Verify
- Final fourth-quarter and full-year 2023 revenue, earnings, cash flow, margins, debt, and liquidity.
- Reconciliation of any non-GAAP financial measures included in Exhibit 99.1.
- Definitive terms, closing conditions, regulatory approvals, and financing for the Asteria Health acquisition.
- Expected impact of the acquisition on revenue, profitability, cash flow, and leverage.
- Whether the preliminary results or acquisition terms changed in subsequent SEC filings.